Abstract
In this issue of HeartRhythm, Cronin et al 1 seek to better understand the service burden commitments of remote monitoring (RM) of cardiac implantable electronic devices. RM of cardiac implantable electronic devices has gained widespread acceptance, with thousands of patients with new implants added monthly to the available monitoring networks. 2 Notably, both the recent Comparative Follow-up Schedule with Home Monitoring (COMPAS) and Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) trials have shown clinical benefit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
